Director, Clinical Operations Program Lead

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook . Company Overview: Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook . Role Summary: The Clinical Operations (Program) Lead is the clinical operations functional representative at the Program team, is responsible for developing and leading the strategy, planning, oversight, implementation and delivery of program and study level clinical operations deliverables as outlined in the clinical development plan (CDP). This individual is responsible for providing advanced functional and technical expertise and insights from both a strategic (decision points, risk) and operational (timeline scenarios, feasibility & financials) perspective to meaningfully contribute and make recommendations to the integrated development plan (IDP) and other key plans, such as the CDP, necessary to advance Dyne’s clinical programs. This individual develops and oversees implementation of program clinical operational strategy, ensuring appropriate considerations that include but are not limited to technical, vendor, quality site/ Investigator, geographical and patient centric considerations for the Program’s lifecycle. This individual may be responsible for one highly complex or multiple medium complexity clinical programs. This role is expected to require up to 20% travel, including international travel. This role is based in Waltham, MA. Primary Responsibilities Include: Leads the development and ongoing refinement of Program level study timelines and scenarios in order to contribute to the CDP, IDP and other high-level strategic plans Provide rigorous, objective information (operational status and updates) to the Program team and, as necessary, Dyne senior leadership to help support strategic project decisions. Takes overall accountability for operational delivery of the clinical studies within a Program and provide appropriate oversight to ensure a high quality, ethical, cost efficient way to meet timelines and patient recruitment goals. Actively participates in Program team and other applicable sub-team meetings, collaborating and integrating with other functions within research and development, medical, and commercial in order to deliver on the CDP/IDP. Responsible for the development and execution of a Program strategic clinical operations plan, taking into account the therapeutic area and underlying science and opportunities for innovation and operational consistency as well as the future clinical, regulatory, and commercial development plan for the molecule. Proactively integrates stage-appropriate needs into the operational strategy. Oversees, mentors and works collaboratively with Clinical Study Lead(s) and other clinical operations and supportive roles